Work

ECOG 3503: A pilot study to determine if downstream markers of EGFR linked signaling pathways predict response to erlotinib (OSI-774) in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.7162

Authors: J. Kolesar, J. Brahmer, S. Li, P. Guaglianone, J. Patel, M. Keppen, M. Hidalgo, D. Carbone, J. Siegfried, J. Schiller

Institutions: Northwestern University, University of Wisconsin–Madison, Johns Hopkins University, University of Pittsburgh, Vanderbilt University, Dana-Farber Cancer Institute, Decatur Memorial Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2127078686

Cites:

Cited by: 5

Related to: 10